CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
FPPdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02332993
NCT02332993N/ACompleted

Nutritional Regulation of Wound Inflammation: Part III

Ohio State University·observational·Posted Jan 7, 2015·Updated Jul 23, 2019

In Brief

An observational study evaluating FPP for Negative Pressure Therapy and 4 related conditions. Completed, enrolled 22 participants across 2 sites.

Detailed Summary

The purpose of this study is to examine the changes that result in the wound healing of a type II Diabetic using Negative Pressure Therapy after 12 weeks of daily supplementation of ImmunAge (Fermented Papaya Preparation (FPP). ImmunAge (FPP) is a supplement made from Carica papaya Linn and is available over the counter. ImmunAge (FPP) is an investigational drug, which means it has not been approved by the U. S. Food and Drug Administration (FDA). Approximately 30 subjects will participate in this study. 15 subjects will take the supplementation and 15 subjects to take no supplementation as the control. The

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 7, 2015
Enrollment StartDec 1, 2014
Primary CompletionSep 8, 2016
Study CompletionFeb 10, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.5 years ago

Interventions

FPPdietary

Made from Carica papaya and represents a sweet and granular substance available over the counter. FPP possesses antioxidant properties that can provide benefit against age-related complications..